Page 32 - JCTR-11-2

Journal of Clinical and
Translational Research US-mediated drug delivery

microbubble- liposome complex: Preclinical investigation control of focused ultrasound blood-brain barrier opening
for Parkinson’s disease treatment. J Control Release. for drug delivery in patients with Parkinson’s disease.
2020;321:519-528. Pharmaceutics. 2022;14(12):2607.
doi: 10.1016/j.jconrel.2020.02.044 doi: 10.3390/pharmaceutics14122607
111. Blesa J, Pineda-Pardo JA, Inoue KI, et al. BBB opening with 121. Meng Y, Pople CB, Huang Y, et al. Putaminal recombinant
focused ultrasound in nonhuman primates and Parkinson’s glucocerebrosidase delivery with magnetic resonance-
disease patients: Targeted AAV vector delivery and PET guided focused ultrasound in Parkinson’s disease: A phase I
imaging. Sci Adv. 2023;9(16):eadf4888. study. Mov Disord. 2022;37(10):2134-2139.
doi: 10.1126/sciadv.adf4888 doi: 10.1002/mds.29190
112. Wang Y, Luo K, Li J, et al. Focused ultrasound promotes 122. Lu H, Le WD, Xie YY, Wang XP. Current therapy of drugs
the delivery of gastrodin and enhances the protective effect in amyotrophic lateral sclerosis. Curr Neuropharmacol.
on dopaminergic neurons in a mouse model of Parkinson’s 2016;14(4):314-321.
disease. Front Cell Neurosci. 2022;16:884788.
doi: 10.2174/1570159x14666160120152423
doi: 10.3389/fncel.2022.884788
123. Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic
113. Feng Y, An R, Zhang Y, et al. AHNAK-modified lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.
microbubbles for the intracranial delivery of triptolide: doi: 10.1038/nrdp.2017.71
In-vitro and in-vivo investigations. Int J Pharm.
2022;629:122351. 124. Al-Chalabi A, Andrews J, Farhan S. Recent advances in the
genetics of familial and sporadic ALS. Int Rev Neurobiol.
doi: 10.1016/j.ijpharm.2022.122351
2024;176:49-74.
114. Xhima K, Nabbouh F, Hynynen K, Aubert I, Tandon A. doi: 10.1016/bs.irn.2024.04.007
Noninvasive delivery of an α-synuclein gene silencing
vector with magnetic resonance-guided focused ultrasound. 125. Van Daele SH, Moisse M, van Vugt JJFA, et al. Genetic
Mov Disord. 2018;33(10):1567-1579. variability in sporadic amyotrophic lateral sclerosis. Brain.
2023;146(9):3760-3769.
doi: 10.1002/mds.101
doi: 10.1093/brain/awad120
115. Lin CY, Tsai CH, Feng LY, et al. Focused ultrasound-
induced blood brain-barrier opening enhanced vascular 126. Nijs M, Van Damme P. The genetics of amyotrophic lateral
permeability for GDNF delivery in Huntington’s disease sclerosis. Curr Opin Neurol. 2024;37(5):560-569.
mouse model. Brain Stimul. 2019;12(5):1143-1150.
doi: 10.1097/WCO.0000000000001294
doi: 10.1016/j.brs.2019.04.011
127. Maurel C, Dangoumau A, Marouillat S, et al. Causative
116. Lin CY, Huang CY, Chen CM, Liu HL. Focused ultrasound- genes in amyotrophic lateral sclerosis and protein
induced blood-brain barrier opening enhanced α-synuclein degradation pathways: A link to neurodegeneration. Mol
expression in mice for modeling Parkinson’s disease. Neurobiol. 2018;55(8):6480-6499.
Pharmaceutics. 2022;14(2):444.
doi: 10.1007/s12035-017-0856-0
doi: 10.3390/pharmaceutics14020444
128. Bradford D, Rodgers KE. Advancements and challenges
117. Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, in amyotrophic lateral sclerosis. Front Neurosci.
et al. Blood-brain barrier opening with focused ultrasound in 2024;18:1401706.
Parkinson’s disease dementia. Nat Commun. 2021;12(1):779.
doi: 10.3389/fnins.2024.1401706
doi: 10.1038/s41467-021-21022-9 129. Corcia P, Lunetta C, Vourc’h P, Pradat PF, Blasco H. Time
118. Pineda-Pardo JA, Gasca-Salas C, Fernández-Rodríguez B, for optimism in amyotrophic lateral sclerosis. Eur J Neurol.
et al. Striatal blood-brain barrier opening in Parkinson’s 2023;30(5):1459-1464.
disease dementia: A pilot exploratory study. Mov Disord. doi: 10.1111/ene.15738
2022;37(10):2057-2065.
130. Sun Z, Zhang B, Peng Y. Development of novel treatments
doi: 10.1002/mds.29134
for amyotrophic lateral sclerosis. Metab Brain Dis.
119. Gasca-Salas C, Pineda-Pardo JA, Del Álamo M, et al. 2024;39(3):467-482.
Nigrostriatal blood-brain barrier opening in Parkinson’s doi: 10.1007/s11011-023-01334-z
disease. J Neurol Neurosurg Psychiatry. 2024;95:1089-1092.
131. Wei Y, Zhong S, Yang H, et al. Current therapy in
doi: 10.1136/jnnp-2023-332967
amyotrophic lateral sclerosis (ALS): A review on past
120. Huang Y, Meng Y, Pople CB, et al. Cavitation feedback and future therapeutic strategies. Eur J Med Chem.

Volume 11 Issue 2 (2025) 26 doi: 10.36922/jctr.24.00061